Genedata combines computational, scientific, and technical expertise with extensive biopharma R&D domain knowledge to deliver user-friendly solutions that are scalable, open, and aligned with industry processes.
Innovating Life Sciences
Genedata transforms data into intelligence with innovative software solutions that support large-scale, experimental processes in life science R&D. Founded in 1997, Genedata delivers enterprise solutions for data analytics that streamline R&D workflows and improve productivity.
Today, most of the leading pharmaceutical, biotechnology, and agrichemical companies, as well as innovative life science research institutions, rely on Genedata.
True Enterprise Solutions
Headquartered in Switzerland with offices throughout Europe, the USA, and Asia, Genedata is privately owned and is driven by its experienced team of scientific, computational, and business experts.
Collaborating with the global leaders in biopharma and life science industries, Genedata combines its Biopharma Platform with significant domain knowledge to deliver innovative and user-friendly solutions that are scalable, open, and aligned with industry processes.
Genedata is passionate about helping customers control R&D costs as they develop safe, next-generation products and therapies.
Board of Directors & Managing Directors
As founder and CEO of Genedata since its inception in 1997, Othmar has brought together many of the most innovative scientists and software engineers who develop sophisticated computational solutions for R&D processes in the life sciences.
Othmar spearheads the successful organic growth of Genedata. This growth is based on a business model committed to delivering innovative solutions, which are built on a deep understanding of underlying business and research processes and developed within a collaborative environment.
Having contributed to many successful industrial research initiatives, Othmar has also served on several Boards of Directors and government expert councils, including for the European Union.
Othmar earned his Ph.D. in Statistics from the University of California at Berkeley.
Hans Peter, who has been with Genedata since its founding in 1997, established the Genedata Phylosopher and the Genedata Biologics business units, and directs their successful growth.
Advancing Genedata’s leadership in science, Hans Peter has pioneered Genedata’s development of in silico methods for genome, pathway, and promoter analysis. More recently, Hans Peter leads the Genedata Biologics group, addressing innovative antibody screening, protein engineering, and biologics production processes.
A recognized expert in computational biology, Hans Peter has been honored with industry awards and is a frequent speaker at industry conferences and seminars. Additionally, he is involved in several government expert councils.
Hans Peter earned his Ph.D. in Physics from the University of Konstanz.
Stephan, who has been with Genedata since 2000, has successfully built the Genedata Screener business unit from the ground up. Additionally, he has been instrumental in developing the Genedata processes for agile product management, post-sales support, and professional services.
He continues to lead the Genedata Screener business unit, overseeing ongoing development and support for the industry’s premier analytical solution for high throughput screening (HTS) and its expansion into high content screening (HCS) and time series data analysis.
An active member of the Society for Laboratory Automation and Screening, Stephan is regularly asked to participate in industry events and roundtable discussions.
Stephan earned his Ph.D. in Biophysics from the Swiss Federal Institute of Technology.
Kurt, who has been with Genedata since 2004, has led the successful year-on-year growth of Genedata in the U.S. by forging strong partnerships with leading pharmaceutical and biotechnology companies, and research organizations.
With his deep understanding of technology and its application to life science research, Kurt leads all business and technology initiatives that advance the adoption of Genedata solutions for life science research with a specific focus on North America.
An American Cancer Society Fellow at the University of California at San Francisco, Kurt has published extensively in the fields of immunology, virology, and informatics.
Kurt earned his Ph.D. in Immunology and Microbiology at the University of California at San Francisco.
Peter has been with Genedata since its founding in 1997. Committed to the highest software quality standards, Peter has been instrumental in the success of Genedata. He established the company’s strong analytical capabilities and continues to drive the development of Genedata’s scalable analytical software modules.
Collaborating with customers, academics, and industry partners, Peter also guides teams in product demonstrations, and provides leadership on data analysis consulting projects and customer training and support.
Leading European academic journals have published Peter’s scientific research in physics and bioinformatics, and he is a highly regarded speaker at industry conferences and seminars.
Peter earned his Ph.D. in Theoretical Physics at the University of Hamburg/Deutsches Elektronen-Synchrotron.
Hideki, who has been with Genedata since 2006, has driven the successful growth of the Genedata KK subsidiary and leads a strong team of business specialists and application experts.
Hideki has extensive experience in Asian pharmaceutical markets combined with a deep knowledge of bioinformatics and cheminformatics software. He is leveraging this expertise as he focuses on further expansion of the Genedata business beyond the pharmaceutical industry.
Hideki has forged close relationships with top Asian life science companies and leading academic institutions, and as a consequence advances development of product offerings with a focus on meeting the specific requirements of the Asian market.
Hideki graduated from Senshu University with a degree in business.
Kevin, who has been with Genedata since 2016, leads the UK office of Genedata scientific consultants and business account managers and is responsible for driving the successful growth of the UK organization.
Kevin joined Genedata after 18 very successful years in global pharmaceutical R&D spanning multiple scientific disciplines as well as on the IT side. Widely recognized in the industry for his forward-looking approaches, Kevin has held numerous public speaking and consortium roles including serving as the chair and coordinator of the European Union eTRIKS IMI project in translational science.
Kevin uses his extensive knowledge and experience in the industry to ensure all Genedata customers can harness the maximum benefit from their science irrespective of the size of their organization.
Kevin holds a degree in Biochemistry from the University of Wales and a post graduate certificate in Health informatics from University of Manchester alongside PMP professional accreditation.
Chung Ping started with Genedata in 2016 as a trailblazer for Genedata business operations in the Asia-Pacific region. He established the Singapore subsidiary with the goal of expanding the organization's presence in the region and to connect with clients who might benefit from Genedata software solutions.
Prior to joining Genedata, Chung Ping had a very successful career in the field of mass spectrometry. Over the years, he has collaborated with scientists across areas of -omics technologies in the context of biopharmaceutical R&D. His interest in the field of big data for life sciences led him to develop a career with Genedata. Besides a successful track record of developing business in the region, Chung Ping has also regularly contributed to the scientific community through publications, presentations at regional scientific meetings, and guest lectures, as well as serving on the main committee of the Singapore Society of Mass Spectrometry.
Chung Ping holds a honours degree in Biological Sciences from Nanyang Technological University, and a MBA from University of Strathclyde.
Solid Science. Built-In Know-How.
Achieve Success with Genedata.